pubrio
Sandoz logo

Sandoz

Public
+2
sandoz.com
制药制造17,000+ employeesFounded 1993🇨🇭 瑞士

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion. Read our community engagement guidelines: http://bit.ly/4ofoggc

成立年份
1993
员工人数
17,000+
行业
制药制造
公司类型
Public Company
股票
six: SDZ.SW
总部
🇨🇭Basel, BS (+2)
专长
制药行业医疗保健制药制造
25 / 51
活跃市场
1
新市场
PE
置信度
多为早期信号
+245%
势头
较上一周期
32 / 100
扩张评分
发展中
阶段18探索中33投入中
138 个信号 · 最近 90 天

全球扩张

实时
TRRUVN
阶段
探索中投入中进入中运营中
+48个市场已锁定
已显示 51 个中的 3 个

解锁市场时间线与信号动态

活动脉搏

最近 90 天内有 150 个信号。

最近 90 天
招聘
73↑ +35%
招聘
营销与公关
77↑ +7500%
广告投放
产品与技术
0
无活动
+2个类别已锁定
已显示 5 个中的 3 个

市场进入时间线

该公司进入各个市场的顺序 — 从最早到最新

1
🇷🇺RU进入的第 1st 个市场 · 2009推进中
投入中
99 个信号投入中 阶段
2
🇹🇷TR进入的第 2nd 个市场 · 2024推进中
投入中
111 个信号投入中 阶段
3
🇻🇳VN进入的第 3rd 个市场 · 2024推进中
投入中
62 个信号投入中 阶段
+48个市场已锁定
已显示 51 个中的 3 个
当前阶段投入中投入资源
置信度36%
开始追踪于2009首个信号

近期信号

团队扩编🇻🇳 VN昨天

10 active postings

团队扩编🇷🇺 RU昨天

54 active postings

注册以查看完整信号动态

了解一下

关于 Sandoz 的常见问题

关于 Sandoz 的业务、市场和增长信号的快速解答。

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion. Read our community engagement guidelines: http://bit.ly/4ofoggc

今天就开启旅程

可以先用平台,也可以先聊聊

你可以自行使用 Pubrio,或让我们的团队协助研究、获客或数据整合。

与团队沟通
Start Journey Image
pubrio

Pubrio 将来自 50+ 本地来源的商业、人物与意向数据整合为全球图谱,帮助 AI 与营收团队洞悉全市场。

© 2026 Pubrio。保留所有权利。